Author’s Reply to Zheng et al.: A Physiologically Based Pharmacokinetic Drug–Disease Model to Predict Carvedilol Exposure in Adult and Paediatric Heart Failure Patients by Incorporating Pathophysiological Changes in Hepatic and Renal Blood Flows-Reference-Cited by-同舟云学术

Author’s Reply to Zheng et al.: A Physiologically Based Pharmacokinetic Drug–Disease Model to Predict Carvedilol Exposure in Adult and Paediatric Heart Failure Patients by Incorporating Pathophysiological Changes in Hepatic and Renal Blood Flows

Published:2015-12-09 Issue:1 Volume:55 Page:139-141
ISSN:0312-5963
Container-title:Clinical Pharmacokinetics
language:en
Short-container-title:Clin Pharmacokinet

Author:

Rasool Muhammad Fawad,Khalil Feras,Läer Stephanie

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology

Link

http://link.springer.com/content/pdf/10.1007/s40262-015-0349-0.pdf

Reference7 articles.

1. Rasool MF, Khalil F, Laer S. A physiologically based pharmacokinetic drug-disease model to predict carvedilol exposure in adult and paediatric heart failure patients by incorporating pathophysiological changes in hepatic and renal blood flows. Clin Pharmacokinet. 2015;54(9):943–62.

2. Li GF, Gu X, Yu G, Zhao SY, Zheng QS. Comment on:"A physiologically based pharmacokinetic drug-disease model to predict carvedilol exposure in adult and paediatric heart failure patients by incorporating pathophysiological changes in hepatic and renal blood flows". Clin Pharmacokinet. 2015;54(9):943–62.

3. Sandek A, Swidsinski A, Schroedl W, Watson A, Valentova M, Herrmann R, et al. Intestinal blood flow in patients with chronic heart failure: a link with bacterial growth, gastrointestinal symptoms, and cachexia. J Am Coll Cardiol. 2014;64(11):1092–102.

4. Muller AF, Batin P, Evans S, Hawkins M, Cowley AJ. Regional blood flow in chronic heart failure: the reason for the lack of correlation between patients’ exercise tolerance and cardiac output? Br Heart J. 1992;67(6):478–81.

5. Maharaj A, Edginton A, Fotaki N. Assessment of age-related changes in pediatric gastrointestinal solubility. Pharm Res. 2015. doi: 10.1007/s11095-015-1762-7